戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  almost 50 years after it was approved as an intravenous anesthetic.
2 rgets for the sedative action of ethanol and intravenous anesthetics.
3  little or no effect on the actions of these intravenous anesthetics.
4 ative, immobilizing, and hypnotic effects of intravenous anesthetics, a role for those receptors is l
5                    Propofol is a widely used intravenous anesthetic agent with antioxidant properties
6                                              Intravenous anesthetic agents are associated with cardio
7 re intravenous antiseizure drug, more than 1 intravenous anesthetic, and intensive care unit admissio
8                             Volatile agents, intravenous anesthetics, and analgesics have all begun t
9 uced the patient's anxiety to the point that intravenous anesthetic/anxiolytic medications were disco
10       This supports the hypothesis that some intravenous anesthetics bind in the betaM3-alphaM1 subun
11 ed arousal states induced by five classes of intravenous anesthetics by relating their behavioral and
12                                              Intravenous anesthetics continue to be a mainstay in the
13                          Multiple continuous intravenous anesthetic drugs (CIVADs) are available for
14                         We discover that the intravenous anesthetic etomidate binds at an intrasubuni
15  to the hypnotic and amnestic actions of the intravenous anesthetics, etomidate and propofol.
16 nally, TLR4 activation was not attenuated by intravenous anesthetics, except for a high concentration
17                                              Intravenous anesthetics exert a component of their actio
18            Propofol is a widely used, potent intravenous anesthetic for ambulatory anesthesia and lon
19  addition, hypnotic sensitivity to two other intravenous anesthetics in HCN1 knock-out mice matched e
20                                              Intravenous anesthetics, including etomidate, propofol,
21 rtical neurons against both inhalational and intravenous anesthetic-induced neurotoxicity.
22                                 Propofol, an intravenous anesthetic, is a positive modulator of the G
23 y hypersensitive to VAs yet resistant to the intravenous anesthetic ketamine [7].
24 nd assayed for their activation by GABA, the intravenous anesthetic propofol and the endogenous neuro
25                                              Intravenous anesthetic propofol binds to 5-lipoxygenase
26                For example, we show that the intravenous anesthetic propofol enhances tonic inhibitio
27 , the volatile anesthetic isoflurane and the intravenous anesthetic propofol inhibit voltage-gated Na
28                                          The intravenous anesthetic propofol is a full agonist (maxim
29                          The activity of the intravenous anesthetic propofol was unaltered from wild-
30 be directly activated and potentiated by the intravenous anesthetic propofol.
31 voflurane), a haloalkane (halothane), and an intravenous anesthetic (propofol) to bovine and human se
32                                          The intravenous anesthetic, propofol, has been shown to incr
33 annels, a diazirine derivative of the potent intravenous anesthetic, R-(+)-etomidate (2-ethyl 1-(1-ph
34                               Propofol is an intravenous anesthetic that produces its anesthetic effe
35  are part of a binding site for propofol, an intravenous anesthetic, we probed propofol's ability to